Colorectal cancer and rectal carcinoma
Research activity includes metastatic colorectal cancer, colon cancer, and rectum cancer, with interest in treatment sequencing, response-driven management, and survival outcomes in advanced disease.
- Metastatic colorectal cancer
- Colon cancer
- Rectum cancer
Clinical work in this area also reflects attention to personalized treatment selection and disease control after standard therapy failure.
Pancreatic cancer and gastrointestinal neuroendocrine tumors
The sponsor is active in metastatic pancreatic adenocarcinoma, local advanced pancreatic adenocarcinoma, and neuroendocrine tumor research, covering both systemic therapy and locoregional strategies.
- Metastatic pancreatic adenocarcinoma
- Local advanced pancreatic adenocarcinoma
- Neuroendocrine tumor
These studies include interest in treatment intensification, retreatment approaches, and radiotherapy-integrated care for complex digestive malignancies.
Peritoneal and ovarian malignancies
Research also addresses malignant peritoneal mesothelioma and ovarian cancer, with focus on advanced peritoneal disease and intraperitoneal treatment strategies.
- Malignant peritoneal mesothelioma
- Ovarian cancer
This area reflects sustained involvement in difficult-to-treat abdominal cancers requiring specialized regional management.
Brain tumors and neurocognitive outcomes
The sponsor funds work in diffuse low-grade gliomas, with attention to neurocognitive status, psychopathology, and quality of life in patients living with central nervous system tumors.
- Diffuse low-grade gliomas
- Neurocognitive functioning
- Quality of life
Clinical interest extends beyond tumor control to functional and psychological outcomes during treatment follow-up.
Breast cancer survivorship and treatment-related fibrosis
Another area of activity concerns patients with severe and radio-induced breast fibrosis after breast cancer, with emphasis on symptom burden, patient-reported outcomes, and breast-related quality of life.
- Breast cancer
- Radio-induced breast fibrosis
- Patient-reported outcomes
This research domain includes supportive care questions linked to long-term treatment effects and symptom monitoring.
